Copyright: ©Author(s) 2026.
World J Clin Oncol. May 24, 2026; 17(5): 118073
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.118073
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.118073
Figure 1 Molecular mechanisms of DNA methylation driving the progression of gastric precancerous lesions.
H. pylori: Helicobacter pylori; EMT: Epithelial-mesenchymal transition.
Figure 2 Clinical translation and application of DNA methylation biomarkers in gastric precancerous lesions.
cfDNA: Cell-free DNA; AI: Artificial intelligence.
Figure 3 Mechanisms of targeted intervention based on DNA methylation in gastric precancerous lesions.
EBV: Epstein-Barr virus.
- Citation: Zeng SH, Wu YQ, Zhang WJ, Wang YT, Xu L, Guo SJ. DNA methylation in gastric precancerous lesions: Molecular mechanisms and clinical translation. World J Clin Oncol 2026; 17(5): 118073
- URL: https://www.wjgnet.com/2218-4333/full/v17/i5/118073.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i5.118073